MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study

D. Nene, M. Choi, A. Yu, M.S Mirian, J.A Small, L.M Jenstad, S. Appel-Cresswell (Vancouver, BC, Canada)

Meeting: MDS Virtual Congress 2020

Abstract Number: 752

Keywords: Non-motor Scales, Parkinsonism

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: The primary objective of this pilot study was to investigate hearing and its relationship to the neuropsychiatric profile, cognition and quality of life in Parkinson’s disease (PD).

Background: Negative consequences of undiagnosed and unmanaged hearing loss such as social withdrawal, depression, and lower quality of life are well documented in the general population. Hearing impairment in Parkinson’s has received only limited attention in the past, possibly because PD patients often report no perceived hearing disability yet negative consequences of hearing impairment might aggravate communication difficulties and social withdrawal.

Method: Participants with PD were recruited in a tertiary movement disorder clinic.  Demographic, audiological, neuropsychiatric (Beck’s Depression Inventory:BDI, Apathy Scale:AS, State Trait Anxiety Inventory:STAI), cognitive screen (MoCA) and quality of life (SF-36) data was collected from each participant

Results: 29 participants (mean age: 66 years, M:F= 1.6:1, mean disease duration 5.2 years) completed the study, assessments were done in the ON state. Even though 65.5% of the participants had normal hearing for age in pure tone audiometry (PTA), functional hearing loss was present in 58.6% (n = 17) participants, defined as scores below the 2.5th percentile on the Hearing in Noise Test (HINT). Poor functional hearing was present in 65% of those with a disease duration of <4 years. The majority of those with poor functional hearing did not perceive a hearing impairment. Both the PTA of the better-hearing ear and the general health subscale of SF-36 were found to be significant predictors of functional hearing in noise. Nine (31%) patients scored in the depressed range of the BDI, 13(45%) in the apathetic range of the AS, 10 (34%) in the anxiety range of the STAI and 9 in the MCI range of the MoCA (remainder normal cognition).  Hearing deficits did not correlate significantly with non-motor symptoms (NMS), including cognition, or with other quality of life measures.

Conclusion: Poor functional hearing was present in the majority of PD participants, occurred early in the disease, was not noticed by participants and was independent of cognition and other NMS. Functional hearing deficits in PD will require further investigation and tailored treatment.

To cite this abstract in AMA style:

D. Nene, M. Choi, A. Yu, M.S Mirian, J.A Small, L.M Jenstad, S. Appel-Cresswell. Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/functional-hearing-impairment-common-in-parkinsons-disease-insights-from-a-pilot-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/functional-hearing-impairment-common-in-parkinsons-disease-insights-from-a-pilot-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley